Breaking News

ZO Launches Sunscreen

August 7, 2013

Medical Oclipse-C gets kudos from Skin Cancer Foundation

The new ZO Medical Oclipse-C Broad-Spectrum Sunscreen SPF 50 recently earned the renowned Skin Cancer Foundation Seal of Recommendation. The company calls it a breakthrough formula that redefines broad-spectrum sun protection.

 
With the addition of fractionated melanin this innovative formulation goes beyond conventional UVA and UVB protection to minimize the damaging effects of high-energy visible (HEV) light, which actually penetrates more deeply into the skin than UVA and UVB rays, potentially causing greater long-term damage. The fractionated melanin found in ZO Medical Oclipse-C Broad-Spectrum Sunscreen SPF 50 interferes with HEV light absorption, helping to provide more complete protection than ever before.

Related End-User Markets:

blog comments powered by Disqus